First Experience with Chemokine Receptor CXCR4–Targeted PET Imaging of Patients with Solid Cancers-Reference-Cited by-同舟云学术

First Experience with Chemokine Receptor CXCR4–Targeted PET Imaging of Patients with Solid Cancers

Published:2016-01-14 Issue:5 Volume:57 Page:741-746
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Vag Tibor,Gerngross Carlos,Herhaus Peter,Eiber Matthias,Philipp-Abbrederis Kathrin,Graner Frank-Philipp,Ettl Johannes,Keller Ulrich,Wester Hans-Jürgen,Schwaiger Markus

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference34 articles.

1. Molecular Imaging of Chemokine Receptor CXCR4

2. Preclinical evaluation of a CXCR4-specific 68Ga-labelled TN14003 derivative for cancer PET imaging

3. Chemokines and cancer

4. How do stem cells find their way home?

5. High-level expression of CXCR4 in breast cancer is associated with early distant and bone metastases

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [68 Ga]Ga-CXCR4 PET/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression;European Journal of Radiology;2024-11

2. Disclosing tumor biology by means of molecular imaging in a patient with malignant melanoma and chronic lymphocytic leukemia;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-15

3. Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma;EJNMMI Radiopharmacy and Chemistry;2024-07-15

4. Radiotheranostics Global Market and Future Developments;Seminars in Nuclear Medicine;2024-07

5. Different extramedullary disease shown in chemokine receptor 4 targeted PET/CT with [68Ga]Ga-pentixafor in patients with Waldenström macroglobulinemia and smoldering disease;Nuclear Medicine Communications;2024-05-15